abs276.txt	objectives		the	agreement	between	clinician-	and	patient-reported	toxicities	andtheir	association	with	poor	tolerance	to	therapy	were	assessed	in	an	olderpopulation	receiving	curative	radiotherapy	(rt)	materials	and	methods		patients	≥	65	years	old	with	newly-diagnosed	head	and	neckor	lung	cancer	receiving	curative	rt	±	chemotherapy	were	enrolled	on	aprospective		observational	study		agreement	between	clinician	(ctcaev4	02)	andpatient	(pro-ctcae		eortc	qlq-c30)	report	of	toxicities	were	assessed	atbaseline		during	treatment		and	post-treatment		the	association	of	clinician-	andpatient-reported	symptoms	with	poor	tolerance	to	therapy	(defined	ashospitalization		>3-day	treatment	delay		change	in	treatment	regimen		or	death)was	assessed	results		among	45	patients		median	age	was	71		60%	had	head	and	neck	cancer		and47%	received	concurrent	chemotherapy	with	rt		in	comparing	ctcae	vs	pro-ctcae	there	was	good	agreement	at	baseline	except	for	fatigue		anorexia		and	pain	where	clinicians	under-reported	the	severity		the	discrepancy	increased	duringtreatment	with	clinicians	reporting	lower	severity	in	≥50%	of	matched	pairs	for4/10	symptoms	assessed		at	follow-up		clinicians	under-reported	severity	in	≥50%of	pairs	for	7/10	symptoms		ctcae	vs	eortc	qlq-c30	mirrored	these	findings	patient-reported	symptoms	of	nausea	and	dysphagia	at	2	weeks	andclinician-observed	symptoms	of	nausea	and	dysphagia	at	4	weeks	were	associatedwith	poor	tolerance	to	therapy	conclusion		clinicians	under-report	toxicities	during	and	after	curative	rt	inolder	patients	with	head	and	neck	or	lung	cancer		select	toxicities	reported	bypatients	early	in	treatment	and	clinicians	later	in	treatment	were	associatedwith	poor	tolerance	to	cancer	therapy		providing	valuable	complementaryinformation	
